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Natural killer (NK) cells provide essential protection against viral infections. One of the defin-
ing features of this lymphocyte population is the expression of a wide array of variable cell
surface stimulatory and inhibitory NK receptors (sNKR and iNKR, respectively). The iNKR
are particularly important in terms of NK-cell education. As receptors specific for MHC class
I (MHC I) molecules, they are responsible for self-tolerance and adjusting NK-cell reactivity
based on the expression level of self-MHC I.The end result of this education is twofold: (1)
inhibitory signaling tunes the functional capacity of the NK cell, endowing greater potency
with greater education, and (2) education on self allows the NK cell to detect aberrations
in MHC I expression, a common occurrence during many viral infections. Many studies
have indicated an important role for iNKR and MHC I in disease, making these receptors
attractive targets for manipulating NK-cell reactivity in the clinic. A greater understanding
of iNKR and their ability to regulate NK cells will provide a basis for future attempts at
translating their potential utility into benefits for human health.
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INTRODUCTION
Natural killer (NK) cells are innate lymphocytes with broad speci-
ficity and a capacity for rapid recognition and activation. They
participate in a wide variety of biological conditions spanning
cancer, autoimmunity, pregnancy, and viral infections. Although
originally identified and named for their ability to spontaneously
lyse tumor cells (1, 2), clear evidence showcasing their impor-
tance comes from studies of virus control in the context of
NK-cell deficiency. Human classical NK deficiency results in
reduced numbers of NK cells, while functional NK deficiency
results in normal NK-cell numbers but impaired responsiveness
(3). Individuals exhibiting either of these conditions consistently
present in the clinic with severe viral infections – especially
herpesviruses (3, 4).
Unlike T and B cells, NK cells do not undergo DNA rearrange-
ments to generate their cell surface receptors. Rather, they express
a broad array of stimulatory and inhibitory NK receptors (NKR)
encoded by genes clustered in the NK gene complex (NKC) and
leukocyte receptor complex (LRC) (5–11). NK cells in both mice
and humans express NKC-encoded C-type lectin-like receptors
including NKG2D, NKG2A/C/E, and CD94. Mouse NK cells also
express diverse Ly49 receptors, another NKC-encoded family of C-
type lectin-like receptors, whereas human NK cells express variable
LRC-encoded killer Ig-like receptors (KIRs) (5–11).
The NKC and LRC represent two of the most variable and
diverse genomic intervals, rivaling the MHC in terms of gene con-
tent (7, 9, 12). Diversification of genomic intervals encoding NKR
is evident in many species (7, 9) and is likely shaped by a variety of
factors influencing fitness and survival, including pathogen resis-
tance, detection of self-MHC I ligands, and reproductive success
(10). Two main points related to NKR variability require empha-
sis: (1) Independent convergent evolution of the NKR in many
species highlights their functional importance; and (2) extensive
intra- and inter-species NKR gene diversity is indicative of their
instability and rapid evolution, likely due to balancing selection
exerted by both MHC and pathogen genetics (9).
NK receptor expression in NK cells is variegated and can vary
greatly from NK cell to NK cell. Interactions between NKR and
their environment establish a balance of signals within the NK cell,
favoring either tolerance or activation (12). Inhibitory (i)NKR
specifically bind MHC class I molecules as ligands, allowing
NK cells to patrol for normal self-MHC expression. Stimulatory
(s)NKR bind to a variety of ligands including viral proteins and
MHC I-related molecules induced by cellular stress pathways (12–
14). While roles for a number of sNKR in NK-mediated virus
control have been established (15–17), the contributions of iNKR
have been more difficult to unravel. Specific detection of viral or
virus-induced host ligands by sNKR has been shown to enhance
NK-cell activation,expansion,and viral clearance. However,a large
body of work in the field also links iNKR activity to NK-cell target
detection, sensitivity to sNKR stimulation, and capacity for effec-
tor function (cytokine production and target lysis). Thus, iNKR are
likely to have prominent effects on immune responses, extending
well beyond the disruption of activation signals and self-tolerance.
Here, we consider data concerning iNKR involvement in immu-
nity. The discussion focuses on the importance of iNKR activ-
ity in a variety of processes including driving NK functional
tuning, shaping viral evasion strategies, enhancing activation
responses, and mediating specific recognition and control of viral
infections.
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INHIBITORY RECEPTORS INCREASE NK-CELL
RESPONSIVENESS
As mediators of NK-cell self-tolerance, iNKR safeguard against
aberrant or chronic immune activation and the development
of autoimmunity (18–24). However, iNKR signaling also leads
to increased basal responsiveness in NK cells (25–30). Cognate
interactions between iNKR and self-MHC I ligands tune the
responsiveness of NK cells. This occurs through an educational
process that has been referred to as “arming” or “licensing.” When
NK cells express an iNKR that can bind at least one self-MHC
I ligand in their environment, they are said to be “licensed.”
These NK cells display increased ex vivo sensitivity to stimulatory
receptor cross-linking compared to “unlicensed” NK cells lacking
self-specific iNKR.
Two proposed models attempt to account for the differen-
tial responsiveness of NK cells stemming from the presence or
absence of self-MHC binding iNKR. The “disarming” model con-
tends that NK cells without any iNKR for self-MHC I are rendered
hyporesponsive due to chronic low-level stimulation; whereas the
“licensing” model predicts that NK cells without iNKR for self-
MHC I simply fail to acquire full reactivity (Figure 1) (26, 31).
Adherence to one or the other of these hypotheses may be too
idealistic, though, as there is evidence to support both and they
may indeed be occurring side-by-side in NK cells. Regardless of
the mechanism, NK cells that sense self at steady state are more
reactive to stimulation and changes in MHC class I expression than
their self-ignorant counterparts.
Such iNKR licensing effectively bestows an added level of sensi-
tivity to self-MHC ligand expression. NK tuning to normal levels
of self-MHC expression broadens NK-cell specificity, allowing
licensed-NK cells to detect and respond against cellular targets
failing to express adequate levels of self-ligand (17, 32, 33). In
short, productive licensing through inhibitory signaling provides
a twofold benefit to NK function. It serves to simultaneously
enhance effector responses (e.g., IFNγ secretion and cytotoxicity)
and broaden the NK-cell’s target specificity to include aberrant
cells that would not be detected by stimulatory receptors alone.
In light of these advantages, it is important to emphasize that
licensing is a tunable process, i.e., that the extent of inhibitory
receptor priming corresponds to the relative increase in NK-cell
reactivity (34–36). Hence, the licensing effect is not a binary read-
out. Instead, it manifests as a rheostat determined by the total
input from iNKR. Whether the enhancement of NK responsive-
ness is actively mediated by iNKR signals or simply the result of
increased disruption of stimulatory NKR signaling is an impor-
tant question that has yet to be resolved. Moreover, the licensing
status of an NK cell is not fixed. Rather, several studies have shown
that the responsiveness of NK cells can be reset after their transfer
from one MHC I environment to another (37–39). These results
suggest that the acquisition of functional reactivity is a dynamic
process that results in continual NK-cell re-education.
While the mechanistic basis of NK-cell education is still unclear,
it is known that the immunoreceptor tyrosine-based inhibitory
motif (ITIM) in the iNKR cytoplasmic tail is required (29). Both
mouse and human iNKR carry at least one ITIM that can bind
cellular phosphatases containing Src homology 2 (SH2) domains.
Phosphatase recruitment further leads to Vav dephosphorylation
and the subsequent disruption of activation signals (Figure 1)
(17). The role of SH2-containing phosphatases in NK-cell licens-
ing and function has also been the subject of investigation (40, 41).
FIGURE 1 | Natural killer education primes NK cells for heightened
effector function. (A) Inhibitory signaling serves a twofold purpose. On one
hand, it can disrupt activation signals from sNKR at several intersections (e.g.,
SHP dephosphorylation of Vav, SHIP dephosphorylation of PIP3, and c-Abl
sequestration of Crk from activation complexes). On the other hand, it also
serves to tune the reactivity of the NK cell to activating stimuli, either through
unknown positive signals transmitted downstream of iNKR ligation (licensing
model) or prevention of anergy (disarming model). One distinct benefit of
self-specific iNKR that has been recently established is the ability to enhance
sNKR inside-out signaling to LFA-1 to promote adhesion and target
recognition. (B) The balance of signals in NK cells determines their reactivity.
NK that do not receive inhibitory signals can be activated in response to
inflammatory stimuli and conditions, but are generally less responsive to
sNKR stimulation (in terms of cytokine production and cytotoxicity) than NK
that receive iNKR input. Whether this occurs via a licensing mechanism,
disarming mechanism, or both is still not fully worked out.
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However, results from these studies have been difficult to interpret.
The effects of SH2-containing tyrosine phosphatase 2 (SHP-2) on
licensing are not well known due to the embryonic lethality of
knockout mice (42). SH2-containing inositol phosphatase (SHIP)
deficient mice exhibit skewed NKR repertoires with increased rep-
resentation of certain iNKR (43). NK cells in these mice appear
to have a defect in the enhancement of IFNγ production but have
intact missing-self recognition in response to reduced iNKR liga-
tion (43, 44). SHP-1 has been studied in more detail than SHP-2
and is reported as the most prevalent phosphatase recruited to
ITIMs during MHC-specific iNKR inhibition (25). In contrast
with SHIP−/−, SHP-1 deficient mice had intact iNKR-mediated
enhancement of IFNγ but a markedly reduced ability to lyse targets
with reduced or absent MHC I expression (29, 45). These results
highlight the complexity of NK-cell education and may suggest
that iNKR license NK cells via multiple, distinct pathways.
Indeed, there is now evidence for direct signaling events down-
stream from inhibitory receptors (17,46,47). Rather than inducing
complete broad-scale dephosphorylation, inhibitory receptor sig-
naling also leads to specific phosphorylation of the small adaptor
molecule, Crk (46). This results in its association with c-Abl and
sequestration from activation signaling complexes (47). While it
is still unknown if this leads to other downstream effects that may
result from inhibitory receptor cross-linking, this discovery opens
the possibility that inhibitory signaling could induce additional
phosphorylation events that have yet to be identified (Figure 1).
Increased target cell adherence during conjugate formation is
another positive effect of NK-cell education (48). Strong LFA-
1-dependent adhesion induces the formation of tight conjugates
between NK cells and target cells (49, 50), as well as the subse-
quent polarization of lytic granules (51). Inside-out signaling from
stimulatory receptors to LFA-1 causes it to shift into an open con-
formation,allowing for a stronger association with ICAM on target
cells (52). Interestingly, cells educated via inhibitory signals were
found to have enhanced activating receptor inside-out signaling
(Figure 1). Following incubation with K562 target cells, activa-
tion signals in licensed-NK cells resulted in more high-affinity
(open conformation) LFA-1 when compared to their unlicensed
counterparts, which resulted in increased tight conjugate forma-
tion, lytic granule polarization, and target cell lysis (48). Thus,
inhibitory tuning of NK cells potentiates increased responsiveness
by enhancing sNKR signaling. Although the mechanistic basis of
this effect on sNKR signaling is unknown, we can infer that iNKR
signaling pathways exert a profound influence on the reactivity of
licensed-NK cells.
Collectively, these studies provide substantial evidence of a crit-
ical role for iNKR signaling in the tuning of NK-cell function.
While unlicensed-NK cells are capable effectors, education via
iNKR provides NK cells with enhanced activation potential and
an added layer of specificity for the detection of MHC class I fluc-
tuations and/or aberrations. Such tuning is essential for the role
of NK cells as sentinels of healthy self-gene expression.
VIRAL EVASION TACTICS UNDERSCORE iNKR IMMUNE
PRESSURE
Evidence for the importance of NK-cell iNKR in viral resistance is
seen in the immune evasion mechanisms employed by viruses.
Common viral strategies to avoid detection by CD8+ T cells
involve the regulation of MHC I expression on the surface of
infected cells. However, viruses must strike a balance between
limiting MHC I presentation of virus-derived peptides and main-
taining sufficient MHC I levels to prevent“missing-self”detection.
Such manipulations have been described for many viruses, partic-
ularly those most susceptible to NK-mediated responses [Figure 2;
reviewed in Ref. (53, 54)]. While many viruses exploit iNKR as
a way to evade immune detection, the targeted nature of these
diverse strategies conveys the prominence of selective pressure
exerted by NK cells and their iNKR.
SELECTIVE MODULATION OF MHC I TO INHIBIT NK CELLS
Human (H)CMV utilizes several immunoevasin proteins to selec-
tively decrease MHC I expression on the surface of infected cells.
Although seemingly redundant, the varied timing of expression,
mechanisms of action, and allelic-specificities of these immu-
noevasins indicate a tightly orchestrated manipulation of class
I expression responsible for HCMV’s successful evasion of the
FIGURE 2 | Viral manipulation of the MHC class I antigen processing
and presentation. The presentation of self- and foreign-peptides on MHC
class I molecules is integral to the regulation of both NK and CD8+T cell
immunity. Viruses have developed multiple strategies to interfere with class
I antigen presentation, with the ultimate goal of evading both innate and
adaptive immune recognition. Manipulation of class I molecules can occur
at various stages of the class I expression pathway: (1) peptide antagonists
produced during proteasomal degradation of cytoplasmic proteins dictate
the affinity of class I interactions with iNKR and CD8+TCR; (2)
immunoevasins interfere with the proper loading and folding of the class I
molecules, and even retain properly folded molecules in the ER; (3) viral
proteins promote the export of class I molecules into the cytosol for
proteasomal degradation or re-direct class I trafficking from the ER to
endo-lysosomal compartments; (4) viral proteins promote the expression of
classical and non-classical MHC molecules, as well as class I mimics, to
specifically inhibit NK-cell activation.
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immune system. Both US3 and US6 retain MHC I in the ER. US3
interferes with tapasin-dependent peptide antigen transport (55–
57), whereas US6 binds to TAP and prevents the proper loading
and folding of all MHC I (58, 59). As neither of these immu-
noevasins directly binds to specific class I alleles, their class I
targets for downregulation are quite broad. US2 and US11, on the
other hand, target and bind to specific, non-overlapping alleles of
HLA-A and -B molecules for dislocation from the Golgi apparatus
and subsequent degradation in the cytosol, leaving residual HLA-
C and -E expression to bind inhibitory KIR and NKG2A/CD94,
respectively (59–61). Indeed, the non-overlapping specificities of
these latter immunoevasins are indicative of the virus’s acquired
responses to the high degree of MHC I polymorphism (62). How-
ever, it is also possible that this arsenal of independent immuno-
evasins and their regulation was driven by iNKR. By encoding for
non-redundant manipulators of class I expression, HCMV selec-
tively regulates MHC surface expression in an attempt to protect
itself from missing-self detection by NK cells.
Similar to HCMV, HIV-1 and cowpox virus (CPXV) down-
regulate surface expression of MHC I molecules to avoid lysis by
CD8+ T cells. HIV Nef binds the cytoplasmic tails of HLA-A and
-B molecules in the ER and then redirects them to endo-lysosomal
compartments for degradation (63). Minor differences in the tails
of HLA-C and -E prevent Nef from interfering with their traffick-
ing to the cell surface, which in turn renders infected CD4+ T cells
resistant to lysis by NK cells expressing the cognate inhibitory KIR
(64–66). In cases where HLA-B is the cognate-ligand for inhibitory
KIR, Nef-mediated downregulation of MHC I ligands may actu-
ally enhance NK-cell control of HIV-1 infection (discussed below)
(67–69). However, pressures from self-licensed-NK cells may also
select against Nef-mediated downregulation of HLA-B, as HLA-
B appears to be more resistant to binding by certain Nef variants
than HLA-A (70). CPXV proteins CPXV012 and CPXV203 dimin-
ish MHC I expression by blocking peptide transport into the ER
and then interfering with MHC I trafficking in the Golgi (71–74).
Further study is warranted to investigate how MHC I interference
relates to HIV and CPXV evasion of NK-cell attack and the effect
of host MHC polymorphism on NK and T cell recognition of
virus-infected targets.
In addition to selective downregulation of allele-specific class
I ligands, viruses also induce MHC I expression to inhibit NK
cells. For example, a nonamer peptide derived from the leader
sequence of HCMV UL40 that resembles the signal peptides of
many HLA-C allotypes, binds to non-classical HLA-E in a TAP-
independent manner (75, 76). This facilitates HLA-E export to the
cell surface where it can engage the NKG2A/CD94 iNKR on NK
cells. The promotion of inhibitory ligands by HCMV is beneficial
and perhaps even necessary for immune evasion, as sequestra-
tion and degradation of classical MHC I molecules prevents the
loading of signal peptides onto HLA-E, leaving the cell surface
largely bare of MHC. However, increased expression of HLA-E
can also render infected cells more susceptible to NK cells bearing
the NKG2C/CD94 sNKR. A recent study of UL40 comparing clin-
ical isolates of HCMV to the AD169 laboratory strain revealed
increased polymorphism in the leader sequence mimic region
from several isolates (77). While these polymorphisms had little
impact on the ability of UL40-derived signal peptides to bind to
and express HLA-E at the cell surface, non-conservative amino
acid variations at specific positions were capable of abrogating
NKG2C/CD94-mediated lysis while preserving inhibition through
NKG2A/CD94.
Murine (M)CMV also encodes several glycoproteins that
modify surface expression of MHC I molecules. MCMV gp40
sequesters loaded MHC I molecules in ER–Golgi intermediate
compartments (78), whereas gp48 re-routes mature MHC I mol-
ecules to endo-lysosomal compartments for degradation (79). To
balance this broad class I downregulation, MCMV gp34 binds
and promotes MHC I expression at the cell surface (80–82).
Indeed, these immunoevasins are both cooperative and antagonis-
tic in function, and through a hierarchy of allele-specific binding,
MCMV regulates surface MHC I expression to evade detection by
NK cells and CD8+ T cells (83–85). Interestingly, gp34 mutations
were found to accumulate over time in MCMV strains (86, 87),
potentially allowing rapid adaptation of its MHC binding speci-
ficity. Thus, MCMV utilizes multiple strategies to fine-tune MHC
I expression and evasion of iNKR+ cells.
Viral microRNAs also have a role to play in evading the
immune system (88). Interestingly, work so far on the subject
seems to suggest a major role for these viral miRNAs in reg-
ulating the expression of certain ligands of the major sNKR
NKG2D (89). For example, at least three separate herpesviruses
have been shown to produce distinct miRNAs that all target the
stress-inducible NKG2D ligand MICB. HCMV, Kaposi’s sarcoma-
associated herpesvirus (KSHV), and Epstein–Barr virus (EBV) all
encode their own miRNA (miR-UL112, miR-K12-7, and miR-
BART2-5p, respectively) that bind adjacent regions of the MICB 3′
UTR and interfere with its translation and expression (90, 91). It
is interesting to note that this mechanism of NK evasion favors
reduced sNKR recognition over increased iNKR inhibition; so
there is not necessarily a direct impact on iNKR signaling. This
shows that viruses exploit the internal regulation of NK cells (i.e.,
the “balance of signals”) either by increasing inhibition or reduc-
ing stimulation to escape NK detection. It is tempting to speculate
here that a licensed NK may have an advantage in the face of MICB
downregulation since they are more sensitive to activation stimuli,
however this has not yet been explored.
EVASION OF NK CELLS THOUGH MOLECULAR MIMICRY
On top of selective editing of the class I repertoire, viruses use
MHC I-related protein mimics that directly interfere with NK
cells. The HCMV glycoprotein UL18, for example, binds to the
iNKR ILT2/LIR-1 to interfere with LIR1+NK-cell mediated cyto-
toxicity (92). For LIR1+ NK cells, the degree of UL18-mediated
inhibition was directly related to the amount of LIR-1 available on
the NK-cell surface. Interestingly, while highly protective against
LIR1+ cells on a clonal level, UL18+ target cells actually increased
the cytotoxicity of LIR1− NK cells through LIR-1-independent
mechanisms. In a polyclonal population of NK cells, this increased
cytotoxicity of LIR-1-cells was generally sufficient to mask the
inhibition afforded by UL18. CPXV OMCP is another MHC I-
related molecule that may interfere with NK cells by antagonizing
NKG2D-mediated NK-cell stimulation (93). In MCMV, m144 ful-
fills an orthologous mechanism of NK-cell inhibition, mimicking
key structural features of the H-2 molecule (94–96). Although
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its cognate receptor is unknown, both functional and biochemi-
cal studies implicate m144 as a key regulator of mouse NK cells
(94, 95, 97). Interestingly, UL18 and m144 share more sequence
and structure similarities with MHC I molecules than they do
with each other, suggesting that convergent evolution led to the
independent acquisition of MHC I mimics due to species-specific
immune pressure (96, 97) in a way reminiscent of the convergent
evolution of iNKR among species.
MCMV m157 is another MHC I-related molecule that may
have specifically evolved to engage NK-cell iNKR (98–100). Dis-
tinct variations in its three-dimensional folds and the lack of
association with β2-microglobulin enables m157 to interact with
iNKR with greater affinity than their cognate MHC I ligands
(101, 102). Discovery of the inhibitory nature of m157 was made
after the initial observations between enhanced viral control and
Ly49H stimulatory receptor recognition of m157 (98, 99, 103–
106). Despite its dominant activating properties in C57BL/6 (B6)
mice and strains bearing Ly49Hb6, it was hypothesized that m157
initially evolved to inhibit NK cells in the wake of broad down-
regulations of endogenous MHC I molecules, similar to m144.
Indeed, the MCMV-susceptible 129/J allele of the iNKR Ly49I
shares substantial sequence similarity with Ly49Hb6 (107). More-
over, Ly49I129 binds to m157-Ig fusion proteins (99) and may even
possess a higher affinity for m157 than Ly49Hb6 (101). Despite the
limitations of fully resolving the inhibitory effects of m157 on
Ly49I129 in vivo, it was demonstrated that 129/J mice infected with
∆m157 virus exhibited limited, but significant, reductions in viral
titers compared to WT BAC-MCMV-infected mice (103). Further
support for m157’s immune evasive role can be gleaned from the
work of Scalzo and colleagues who found that m157 variants iso-
lated from wild outbred mice bind an array of inhibitory Ly49
with a wide range of affinities while very few of them activate
Ly49H (100).
It is important to note that infection and immunity are inextri-
cably linked in an evolutionary arms race (10, 108, 109). While
immune surveillance mechanisms represent important targets,
successful viral evasion strategies can paradoxically become trig-
gers for immune stimulation. Importantly, scientific findings from
models investigating viral evasion and immunity are inherently
based on a fixed point in evolution. Although viruses rapidly evolve
to evade NK-cell detection, the immune system of a population is
also constantly evolving to overcome these hurdles (110).
This observed co-evolution has been independently substanti-
ated by de Boer and colleagues through in silico modeling. Using
a simplified model of human KIR diversity and a herpesvirus-like
agent that could downregulate or promote the expression of decoy
MHC I molecules, they demonstrated that viral evasion strategies
invariably informed the degree of KIR specificity for HLA, and that
the existence of decoy models necessitated by a diverse KIR reper-
toire to distinguish host ligands from decoys (111). The fact that
highly variable and rapidly evolving regions of the genome encode
so many iNKR strongly indicates their importance in combating
viral infections that are also continually adapting to their hosts.
EVIDENCE FOR LICENSED-NK-MEDIATED VIRAL CONTROL
Many sNKR (e.g., Ly49H and NKp46) have been shown to
specifically bind proteins expressed by certain viruses including
herpesviruses, influenza, and poxviruses (98, 99, 104, 112–115).
This allows NK cells to specifically recognize and eliminate viral
pathogens. As an example, human XMEN deficiency, which
results in an Mg2+ defect and poor NKG2D expression on NK
cells, was overcome with Mg2+ supplementation that led to
increased NKG2D expression and enhanced EBV clearance (116).
NKG2C is another sNKR frequently expressed by NK-cell subsets.
NKG2C+NK cells preferentially expand after exposure to HCMV
(117), potentially indicating specific activation in response to the
infection.
Since iNKR bind highly polymorphic MHC I ligands and pre-
vent the lysis of normal, healthy cells, viral modulation of MHC
I molecules resulting in a loss of self-MHC elicits iNKR release
and lysis of infected cells. While this general recognition mech-
anism is well established, the contribution of iNKR to specific
recognition and clearance of viral infections is less clear. A grow-
ing body of literature now documents that iNKR+ NK cells also
expand and acquire greater reactivity after viral exposure, which
raises additional questions: Is NK-cell subset expansion neces-
sarily linked with specific recognition and lysis of infected target
cells? What mechanism(s) can explain increased responsiveness
of self-licensed iNKR+NK cells? Can licensed-NK cells recognize
and respond to viral infection in the face of viral evasion? Does
a licensed-NK-mediated response to viral infection result in NK-
cell memory? These and other important questions are presently
unanswered and provide the framework for further review of data
alluding to the critical role of licensed-NK cells in viral defense.
EXPANSION OF iNKR+ NK CELLS IN RESPONSE TO VIRAL INFECTION
Previous studies have documented that certain iNKR+ NK-cell
subsets consistently expand after viral exposure (105, 118). Sev-
eral scenarios may account for this. First, iNKR+ NK subset
expansion may be related to non-specific effects associated with
broad immune activation or inflammation. Expression of NKR
is variegated, but unequal within the NK compartment. Thus,
certain highly represented iNKR may simply have an expression
advantage and will be primed to expand during NK proliferation.
Alternatively, accumulation of iNKR+ NK cells could result from
co-expression with an unknown NKR that is required for the spe-
cific recognition of and response to infection, essentially making it
a biomarker of expansion. Lastly, a given iNKR+ NK subset may
increase as the result of the iNKR itself specifically detecting and
responding to an infection. Expansion due to specific recognition
has been shown for the stimulatory Ly49H receptor and specific
recognition by a licensed-NK cell could result in a similar out-
come. Importantly, these possibilities are not mutually exclusive,
and NK-cell expansion could result from multiple, simultaneous
mechanisms.
In B6 mice, expansion of the iNKR Ly49G2+ (G2+) NK-cell
subset is a common observation. This G2+ NK-cell expansion
appears to occur non-specifically in response to a wide spectrum
of conditions, including diverse viral and bacterial infections, ster-
ile stimulation of the immune system, and hematopoietic stem
cell transplant (HSCT) (119, 120). However, this is unlikely to be
a general feature of iNKR since a propensity for expansion has
not been observed with any other inhibitory Ly49+ NK subset.
Rather, selective G2b6 allelic regulation or epistatic interactions
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could affect its expression in NK cells. This is supported by studies
showing G2balb+ NK cells failed to similarly expand after poly
I:C treatment or MCMV infection (85, 119, 121). Even in F1
mice expressing both G2b6 and G2balb receptors, G2b6+ NK cells
expanded to a greater degree when directly compared to G2balb+
NK cells (119). Further study is needed to clarify the role of G2b6+
NK cells in response to conditions that elicit NK-cell expansion
and what this propensity for expansion may mean.
On the other hand, G2c57l+ NK cells were found to selec-
tively expand and control MCMV infection in the presence of the
self-MHC I ligand Dk. The proportion of G2+ NK cells reliably
increases in response to MCMV infection when Dk is expressed.
However selective increases in G2+ cell number have been most
evident in mice given relatively high dose MCMV infection (122).
This suggests that the G2c57l+ NK cells are uniquely reactive
against MCMV targets and, as a result, preferentially accumulate.
Extensive genetic analysis has shown that G2+NK-mediated viral
control is evident over a large range of infectious MCMV doses and
it is always highly correlated with expression of the self-ligand Dk
(123, 124). That the increase in NK-cell numbers is dose depen-
dent further supports that this is a specific response to MCMV
infection. Two major questions requiring further study arise from
these observations: (1) Is the licensed-NK response against MCMV
dependent on a threshold level of viral infection? and (2) Does the
licensed-NK response cooperate with sNKR (e.g., Ly49P and/or
NKG2D) recognition of key targets to mount the observed NK-cell
expansion?
Human studies have documented expansion of NK subsets
marked by combinations of sNKR and self-specific inhibitory
KIR (e.g., NKG2C and iKIR) (16). This feature is prominent in
HCMV infection (117, 125–131), but may also occur in han-
tavirus (132), chikungunya virus (133), HIV-1 (125, 126, 134), and
hepatitis infections (135). Unfortunately, extensive co-infection
has made it difficult to resolve if the observed NK-cell expan-
sion associated with the latter four is HCMV-dependent. However,
a study on EBV and CMV co-infection showed that while all
CMV seropositive children had increased NKG2C+ NK cells, the
amount of NKG2C skewing was even greater in patients that were
CMV/EBV double-seropositive (136). While still inconclusive, this
could suggest that the co-infection can increase the NKG2C rep-
resentation either by providing additional, non-specific effects
from EBV infection or that the CMV-experienced NKG2C+ NK
may specifically respond to the EBV infection. An important
issue to be addressed is whether the self-licensed KIR on the
expanded cells are simply endowing the NKG2C+ cells with
an enhanced ability to expand or are explicitly contributing to
specific viral recognition and NK activation. Additionally, these
NKG2C+ cells have been described by some as memory NK (128),
which presents the intriguing possibility that iNKR could mark
memory NK.
A study by Alter et al. (137) has also reported that KIR3DS1+
and KIR3DL1+ NK cells expand in peripheral blood during HIV
infection. However, in related work, only the KIR3DS1+ cells were
observed to expand (138). Nonetheless, the expansion depended
on the presence of KIR3DL1, and individuals with two copies of
KIR3DL1 exhibited a clear enhancement in KIR3DS1 expansion
over those with one copy. While this undoubtedly indicates a role
for the iNKR, its relationship with the stimulatory receptor is still
unclear.
SPECIFIC iNKR RESPONSES TO VIRAL INFECTIONS
It was the pioneering work of Scalzo and Shellam, studying genetic
control of the host response to MCMV, which led ultimately to the
discovery of Ly49H – a major MCMV resistance factor expressed
in B6 mice (139). Ly49H binding to MCMV m157 was shown to
increase NK-cell proliferation and direct lysis of MCMV-infected
target cells (98, 99, 140). Scalzo’s studies further revealed that the
B6-related MA/My mouse strain also relies on NK cells to mediate
MCMV resistance (141). This result prompted extensive genetic
screening for additional host genetic factors that protect against
viral infection.
We have used classical genetics approaches to analyze the off-
spring obtained by crossing MA/My with C57L (MCMV suscep-
tible), another B6-related mouse strain. Because the NKC-Ly49
haplotype common to both strains differs from B6 (142), it was
reasoned that either a minor NKR polymorphism or an NKC-
independent effect produced the difference in viral control. Using
a parallel genetics screen, Vidal and coworkers compared MA/My
with the BALB (also MCMV susceptible) mouse strain (143). Both
genetic approaches mapped a critical interval centered on the gene
coding for MHC I Dk (122, 143, 144). Its role in MCMV resistance
was verified in C57L-derived transgenic Dk mice and in FVB-
derived (also MCMV susceptible) class I null mice (123, 145).
Together these studies demonstrated that MHC and non-MHC
genetic factors regulate NK-mediated MCMV resistance and that
the MHC I Dk molecule itself has a major effect on viral control.
MHC I Dk expression was expected to correspond with
enhanced MCMV target detection and lysis via a sNKR, analogous
to Ly49H+ control in B6 mice. Ly49P was proposed to mediate
MCMV control based on genetic analysis of the resistance pheno-
type and its recognition of MCMV-gp34-associated Dk molecules
on infected cells (113, 143). However, its role has been difficult
to verify in vivo without monospecific mAbs for detection and
immunodepletion of Ly49P+ NK cells. NKG2D+ NK cells could
also contribute to Dk-mediated MCMV resistance (85). Despite
these possibilities, we found that Dk-mediated MCMV resistance
in MA/My and C57L-derived Dk+ mice was abrogated by spe-
cific immunodepletion of G2+NK cells. Diminished virus control
due to G2+ NK-cell deficiency was observed after treatment with
either of two different G2-specific mAbs, which verifies the crucial
role of the subset in viral detection and clearance (122, 123).
However, iNKR signaling might also interfere with sNKR acti-
vation and viral control. This was examined in neonatal B6
mice adoptively transferred with adult NK cells. MCMV-specific
Ly49H+ (H+) NK cells sorted into self-licensed Ly49C/I+ and
unlicensed Ly49C/I− NK subsets were assessed for their ability to
confer viral control (146). Despite the fact that all H+ cells became
activated after MCMV exposure, the unlicensed-NK cells exhibited
more effective viral control (146). These data demonstrated that
unlicensed-NK cells could have a dominant role in viral clearance,
particularly when viruses successfully escape licensed-NK cells.
Although MCMV evaded and perhaps even exploited self-
licensed-NK-cell detection in the above B6 mice, differences in
the different models of NK-mediated viral immunity suggest that
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licensed-NK-mediated viral control may depend on specific recog-
nition of virus-infected targets via altered MHC I sensing. This
question was further tested in a large-scale genetic analysis of the
host response to MCMV (124). More than 200 mice disparate
for the G2c57l cognate-ligand, Dk, were analyzed for immune and
NK-cell features in the response to infection, in parallel with viral
control. Remarkably, the results demonstrated that G2 expression
on NK cells, the percentage of G2+ NK cells before infection and
their expansion afterward, in addition to MCMV resistance, were
all linked to the presence of Dk in the genome. We infer from
these results that self-Dk-licensed-NK cells were effectively poised
to efficiently recognize and respond to targets, which led to more
effective sNKR signaling, lysis of infected cells, and viral control.
The results above predict that licensed-NK cells may also con-
tribute viral control in B6 mice, as long as one or more iNKR ade-
quately recognize altered expression of a key self-ligand. In agree-
ment with this, Murphy and colleagues reported that licensed-NK
cells selectively expanded following MCMV exposure in syngeneic
HSCT recipients, which corresponded to increased viral control
(147). A similar result was observed in allo-HSCT recipients,which
implies that licensed-NK cells were generally more responsive to
MCMV in transplanted recipients (148). An intriguing possibility
is that a licensed-NK response to MCMV is actively suppressed by
regulatory T cells and TGFβ in B6 mice, but becomes measurable
after HSCT and in Treg- or TGFβ-depleted mice (147). Though
this seems inconsistent with MCMV gp34-mediated interference
with iNKR detection, it may be possible that gp34 stabilization of
critical self-ligands is less effective in the setting of HSCT. Indeed,
NK-cell reactivity is sensitive to MHC I expression after HSCT
(149, 150), and the functional reactivity of licensed-NK cells in
HSCT patients was found to be responsive to self-ligand expres-
sion on donor-derived hematopoietic cells (i.e., NK are function-
ally licensed on transplanted donor cells following HSCT) (151).
Further work is needed to fully understand the genetic and envi-
ronmental impacts on NK-cell licensing and reactivity and how
these influence NK behavior during infection.
Human studies also provide evidence that individuals with
a given configuration of matched iNKR:HLA class I may
exhibit enhanced viral control. Correlations between matched
inhibitory KIR and HLA have been observed in responses
to HIV-1 (3DL1:HLA-Bw4), HCV (2DL3:HLA-C1), influenza
(3DL1:HLA-Bw4; 2DL2/DL3:HLA-C1), and vaccinia virus (VV)
(NKG2A:HLA-E) [(152); reviewed in Ref. (16, 153)]. These asso-
ciations provide evidence for a direct contribution of iNKR and
licensed-NK cells to virus control.
As discussed above, 3DL1/S1+ NK cells can expand during
HIV-1 infection. This expansion is dependent on the expression of
the cognate-ligand for these KIR in the individual (HLA-Bw4-80I)
(137, 138). Individuals who express this particular HLA exhibit
better control of HIV viremia as well as significant protection
from developing AIDS (67). In a group of controllers expressing
the 3DL1:HLA-Bw4 pair, protection was more strongly associ-
ated with high NK-cell activity than CD8 T cell responses (69).
HIV-1 peptide antagonism, in part, may account for these obser-
vations: the HLA-Bw4 restricted immunodominant Gag240–249
TW10 T cell epitope is targeted by CD8+T cell effectors early after
infection. HIV-1 variants of the TW10 epitope, while successful at
evading CD8+ T cells, often interfere with 3DL1 binding to its
cognate-ligand and thereby potentially render infected cells more
susceptible to “missing-self” detection by NK cells (154). In addi-
tion, expression of increasing levels of strongly inhibitory 3DL1
in conjunction with its ligand enhances the observed protective
effect of this iNKR, further strengthening the link between this
KIR:HLA pair and HIV control (68).
Genetics studies have also indicated a potential role for HLA-C
(alleles of which can serve as ligands for 2DL1, 2DL2, and 2DL3)
expression in HIV control, but the importance of NK cells and
KIR:HLA pairing in this observation is still uncertain (155–160).
Some work has indicated that 2DL2 exerts significant pressure
on HIV. Individuals with this iNKR have a prevalence of HIV-
polymorphisms in a region spanning the Vpu and Env proteins.
These polymorphisms allow binding of 2DL2 upon HLA-C pre-
sentation whereas the HIV wild type sequences do not (161). In a
related study screening 217 different Gag peptide sequences, only
11 were found to stabilize HLA-Cw-0102, and of those 11, only
one of these could mediate inhibition of 2DL2 expressing NK cells
(162). These studies suggest that, even though HLA-C is not mod-
ulated by Nef on the surface of infected cells, many HIV peptides
are inefficient at inhibiting 2DL2+ NK cells, pressuring the virus
to rely on peptide diversification during infection of individuals
with 2DL2.
Natural killer cells are generally activated in response to HCV
infection (when compared with NK from uninfected controls),
but NK cells positive for 2DL2/L3 tended to exhibit increased
degranulation in response to K562 targets; particularly in cases
of self-limited infection (163). Individuals homozygous for the
2DL3:HLA-C1 pair exhibit enhanced control of the virus follow-
ing low-dose exposure and this partnership is also associated with
spontaneous clearance of the infection (164, 165). In addition, the
homozygous genotype is correlated with apparent resistance to
infection in i.v. drug users (prolonged seronegativity despite con-
tinual exposure) and positive responses to treatment after HCV
infection (166).
In a model of human influenza A virus (IAV) infection, NK cells
from subjects homozygous for 2DL3 and HLA-C1 were more reac-
tive to IAV infected cells than those from individuals homozygous
for the 2DL1:HLA-C2 ligand pair (167). Another study looked at
the influence of 3DL1, 2DL1, and 2DL2/3 in H1N1/09 infected
ICU patients (2009 pandemic IAV strain). The results showed that
individuals expressing all three iNKR had the lowest risk of death
and that ICU patients exhibited decreased ligation of 3DL1/S1 by
HLA-Bw4 and 2DL1 by HLA-C2 (168), suggesting that stronger
interactions between these KIR:HLA pairs may be protective on
some level.
While the human NK response to VV infection appears to
involve NK cells to some degree, the role of iNKR:HLA has not
been rigorously studied. However, an in vitro investigation using
an autologous cell system showed differences in VV reactivity
among NK subsets from an individual subject. NK cells expressing
high levels of NKG2A were far more efficient at lysing VV infected
cells than their 2DL1+ or NKG2Adim counterparts (152). This
increased lysis was abrogated by rescuing HLA-E expression on
target cells, indicating the activity was due to NKG2A-mediated
detection of reduced HLA-E.
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Several possibilities could account for the apparent benefits
of these genetic pairings: (1) KIR:HLA pairings may correspond
with more effective NK-mediated viral control. Early control of
viral replication and/or less severe inflammation may correspond
to less morbidity and mortality over time. (2) Genetic pairings
favoring NKR and HLA could affect NK-mediated regulation of
adaptive immune responses. More efficient priming of T cells and
less interference with T cell mediated immunity could substantially
augment viral control and clearance. (3) Genetic pairings might
affect other immune cell features (e.g., DC numbers and/or cos-
timulatory molecule expression) that have the potential to affect
NK cells and/or T cells needed to further control viral infection
and replication. (4) Licensed-NK cells may regulate other types of
NK cells, including unlicensed-NK cells, to mount a more vigorous
attack against infected targets. We speculate that iNKR-mediated
sensing of viral targets can enhance the responsiveness of NK cells
to stimulatory receptor signaling and augment their capacity to
lyse infected targets. It will be important to rigorously investi-
gate these possibilities in the future and identify the mechanisms
through which iNKR-licensed-NK cells can augment immunity
and virus control (Figure 3).
CLOSING REMARKS
Important insight into the benefits of iNKR-mediated enhance-
ment of NK-cell reactivity has been gleaned from analyzing NK-
cell responses during viral infection. It is known that iNKR tune
NK cells to efficiently detect and lyse target cells that lack self-
MHC I expression, including virus-infected cells. Viral immune
FIGURE 3 | Summary of proposed beneficial effects of licensed-NK
cells. NK Licensing potentially impacts the immune response in a variety of
ways. Benefits may manifest directly as NK specific recognition or indirectly
via effects on their environment and other cells.
evasion strategies that target iNKR+ NK cells lend credence to
their importance in defending against viral infection. The value of
iNKR in immunity and survival is also evidenced by their “con-
served diversity.” This trait is reminiscent of MHC polymorphism
shaped by co-evolution with diverse pathogens. It is clear that NK-
cell responses are intimately tied to the expression and diversity
of iNKR and MHC I. Ultimately, the receptor–ligand interactions
between these two protein families can shape NK-mediated immu-
nity, host protection, and evolutionary success. Further study of
iNKR in viral immunity should yield better understanding of NK-
cell education and its functional role in viral resistance. Learning
more about iNKR and the regulation of NK cells should also help
in realizing their potential for clinical applications in chronic infec-
tion, transplantation, tumor immune therapy, and/or immune
deficiency.
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